Sarepta Therapeutics Ownership | Who Owns Sarepta Therapeutics?
Sarepta Therapeutics Ownership Summary
Sarepta Therapeutics is owned by 44.61% institutional investors, 5.17% insiders, and 50.22% retail investors. Tudor investment corp et al is the largest institutional shareholder, holding 70.23% of SRPT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.06% of its assets in Sarepta Therapeutics shares.
SRPT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Sarepta Therapeutics | 44.61% | 5.17% | 50.22% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tudor investment corp et al | 68.83M | 70.23% | $63.35M |
| Blackrock funding, inc. /de | 14.28M | 14.25% | $307.38M |
| Vanguard group | 11.81M | 11.78% | $254.17M |
| Blackrock | 10.32M | 10.98% | $1.63B |
| State street | 5.30M | 5.41% | $102.23M |
| Janus henderson group | 4.33M | 4.54% | $526.20M |
| Erste asset management gmbh | 2.73M | 2.72% | $58.73M |
| Abrdn | 2.25M | 2.25% | $48.45M |
| Two sigma investments, lp | 2.14M | 2.18% | $41.19M |
| Ubs group | 2.06M | 2.05% | $44.30M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Boxer capital | 650.00K | 5.41% | $102.70M |
| Ghost tree capital | 55.00K | 2.72% | $8.69M |
| Bioimpact capital | 700.00K | 2.21% | $13.49M |
| Opaleye management | 585.00K | 1.59% | $11.27M |
| Boxer capital management | 250.00K | 1.54% | $4.82M |
| 683 capital management | 990.00K | 1.00% | $19.08M |
| Union square park capital management | 105.00K | 0.72% | $2.02M |
| Adar1 capital management | 349.81K | 0.63% | $6.74M |
| Corton capital | 12.02K | 0.57% | $231.63K |
| Quinn opportunity partners | 376.24K | 0.51% | $7.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tudor investment corp et al | 68.83M | 0.11% | 68.78M |
| Blackrock | 10.32M | 0.04% | 4.36M |
| First trust advisors lp | 1.94M | 0.03% | 1.31M |
| Blackrock funding, inc. /de | 14.28M | 0.01% | 1.08M |
| Vanguard group | 11.81M | 0.00% | 993.28K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -2.67M |
| Wellington management group llp | - | - | -2.53M |
| Farallon capital management | - | - | -2.34M |
| Exome asset management | - | - | -2.00M |
| Qube research | - | - | -1.60M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Highbridge capital management | 400.00K | 0.27% | 400.00K | $8.61M |
| Public sector pension investment board | 381.17K | 0.03% | 381.17K | $7.35M |
| Norges bank | 370.70K | 0.00% | 370.70K | $7.98M |
| Silver point capital | 278.28K | 0.28% | 278.28K | $5.36M |
| Mirador capital partners lp | 139.98K | 0.41% | 139.98K | $3.01M |
Sold Out
| Holder | Change |
|---|---|
| Harbor investment advisory | -1.00 |
| Bokf, na | -1.00 |
| Twin peaks wealth advisors | -1.00 |
| Financial gravity asset management | -1.00 |
| Hfm investment advisors | -1.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 198 | -45.45% | 44,714,234 | -48.61% | 44 | 0.57% | 113 | -35.43% | 39 | -62.86% |
| Sep 30, 2025 | 163 | -60.63% | 42,318,819 | -50.10% | 43 | 0.58% | 77 | -65.47% | 57 | -36.67% |
| Jun 30, 2025 | 410 | -12.02% | 84,724,983 | -2.96% | 86 | 1.07% | 222 | 2.30% | 89 | -42.58% |
| Mar 31, 2025 | 23 | -95.40% | 6,342,126 | -92.89% | 6 | 0.07% | 12 | -95.02% | 7 | -95.39% |
| Dec 31, 2024 | 187 | -62.75% | 19,880,204 | -77.21% | 20 | 0.25% | 88 | -61.40% | 54 | -65.82% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.36M | 6.06% | 6.36M |
| iShares Core S&P Mid-Cap ETF | 3.20M | 3.28% | -5.78K |
| First Trust NYSE Arca Biotech ETF | 3.41M | 3.25% | 14.97K |
| American Funds Growth Fund of Amer A | 3.15M | 3.25% | -5.26K |
| State Street® SPDR® S&P® Biotech ETF | 3.37M | 3.21% | -18.02K |
| Capital Group Growth Fnd of Amer Comp | 3.15M | 3.21% | -5.26K |
| Vanguard Total Stock Mkt Idx Inv | 3.19M | 3.03% | 8.61K |
| Vanguard US Total Market Shares ETF | 2.85M | 2.94% | 2.16K |
| American Funds AMCAP A | 2.66M | 2.74% | 133.61K |
| Capital Group AMCAP Composite | 2.66M | 2.71% | 133.61K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 16, 2025 | Estepan Ian Michael | Chief Operating Officer | Sell | $294.20K |
| Mar 12, 2025 | Nicaise Claude | - | Sell | $248.20K |
| Dec 12, 2024 | Wigzell Hans Lennart Rudolf | - | Sell | $1.31M |
| Dec 05, 2024 | Boor Kathryn Jean | - | Sell | $205.40K |
| Aug 30, 2024 | Estepan Ian Michael | Chief Financial Officer | Sell | $822.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 1 |
| 2024 Q3 | 3 | 1 |
SRPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools